Developments in bioinformatics, and in particular AI, are fuelling important advances in the biotech and digital health space. The wealth of genetic and other information that can now be gleaned from experiments combined with the increasing power of AI underpins many commercially important digital health inventions. These important bioinformatics advances, for example, in AI-based cancer diagnosis or in silico drug design, can be patent protected to provide commercially useful protection to maintain your business’ position at the forefront.

HGF works on these advances for our clients which include global corporations, including pharma, SMEs, and prestigious universities. We advise on patent protection and trade secret protection, developing an IP strategy that provides the best protection for their bioinformatics and AI inventions.

We have worked on, for example, next generation sequencing analyses; AI-based cancer diagnostics (based on images or sequencing data); AI 3D structure analysis; small molecule in silico drug design; microbiome sequencing; AI-based patient groupings for personalized medicine; AI microbe detection and AI-based immunotherapy drug design.

Bioinformatics and AI inventions like these require a depth of experience in the crossover area between life sciences, electronics, and maths. Because of this, we have built a dedicated team of attorneys who have experience in this crossover area: life sciences attorneys with computational biology and AI backgrounds; as well as electronics attorneys and mathematics attorneys with further degrees or patent experience in life sciences.  The members of our team have drafted and successfully prosecuted bioinformatics and AI applications; defended key bioinformatics patents in opposition; and provided FTO analyses.

Trade secret protection is also key to digital health due to the wealth of value in the databases typical of AI inventions. Our team therefore also includes IP solicitors who, alongside our experienced attorneys, can put trade secret protection in place.

For more information about the team, click here.